Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 31 for “"Cancer Dormancy"”.
-
Pathway Analysis of Breast Cancer Dormancy
Following primary treatment for breast cancer, residual tumor cells can lie dormant in the body for decades before giving rise to recurrent tumors, which are invariably fatal. To date, little is known about the biology of breast cancer recurrence, as well as the biology of how the dormant state is …
-
Treatment-Induced Breast Cancer Dormancy and Relapse
When breast tumor cells encounter stress due to cancer therapies, they may enter a dormant state, escaping from treatment-induced apoptosis. Dormant cells may eventually regain proliferative capabilities and cause recurrent metastatic disease, which is the leading cause of mortality in breast …
-
The role of AXL in prostate cancer dormancy
… metastases in the bone marrow of prostate cancer patients represents lethal incurable disease. Metastases that emerge years or decades after elimination of the primary tumor are thought to be derived from dormant cancer cell ‘seeds’ that disseminated during primary tumor development. In …
-
JAK-STAT SIGNALING IN BREAST CANCER DORMANCY AND RECURRENCE
Breast cancer is the leading cause of cancer-related mortality among women worldwide, which is principally attributable to recurrent tumors that arise from residual tumor cells (RTCs) that survive primary tumor treatment. Due to the long latencies for recurrence observed in many patients, breast …
-
Modeling Breast Cancer Dormancy and Recurrence Following Oncogenic Pathway Inhibition
Breast cancer recurrence is the primary cause of mortality in breast cancer, and although advances have been made in the treatment of primary breast cancer, recurrent breast cancer remains uncurable. Targeted therapy has had a major impact on survival across multiple cancer types, including breast …
-
The Role of HBP1 in Controlling Metastatic Breast Cancer Dormancy
… to a detectable level (1). The phenomenon of cancer dormancy and reappearance leads to a recurrence of disease and is a major contributor to mortality. Within DTCs, dysregulated genes and transcription factors determine the balance between dormancy and reawakening (1). HMG-box transcription …
-
The Role of the Tumor Microenvironment in Breast Cancer Dormancy and Recurrence
<p>Over half of breast cancer related deaths are due to recurrence five or more years after initial diagnosis and treatment. This latency suggests that a population of residual tumor cells can survive treatment and persist in a dormant state for many years. The role of the microenvironment in …
-
Nuclear Basic Fibroblast Growth Factor Regulation of Triple-Negative Breast Cancer Dormancy/Recurrence
… treatment for triple-negative (TN) breast cancer. Although some TN breast cancers respond initially to neoadjuvant chemotherapy, the majority of patients die within three years of treatment due to recurrent tumor growth. Developing ex vivo models for TN breast cancer recurrence and defining …
-
ELUCIDATING THE ROLE OF PTEN AND THE FOCAL ADHESION PATHWAY IN BREAST CANCER DORMANCY
Most breast cancer related deaths are the result of metastatic recurrence. The long latencies between initial primary tumor treatment and detection of recurrent disease suggest that surviving residual tumor cells pass through a state of dormancy. The tumor suppressor PTEN is associated with poor …
-
Dissecting the Intrinsic and Extrinsic Regulators of Prostate Cancer Dormancy in the Bone Microenvironment
Metastatic disease is the primary driver of cancer-related mortality. In prostate cancer (PCa), patient survival decreases dramatically once the disease spreads to distant organs, with over 80% of metastases occurring in the bone. This dissemination is often followed by a clinically silent period …
-
Biomaterial Platforms to Study Cancer Dormancy and Develop Therapeutic Strategies for Breast and Ovarian Cancers
In breast and ovarian cancer, the primary source of mortality is metastasis. Even in patients who are thought to be cancer-free after initial treatment, metastatic recurrence after months or years of asymptomatic latency period in patients is common in both cancers. Cancer cells that stay dormant …
-
Method development for identification of targetable genes in ADT-induced prostate cancer dormancy : the case of Interleukin-33
Background: Prostate cancer is the most common cancer in Canadian men. Androgen receptor drives PCa, and androgen deprivation therapy is the standard of care for advanced PCa, initially ADT elicits a response but often leads to ADT-induced dormancy that precedes relapse to castration-resistant PCa, …
-
A New Mathematical Theory for the Dynamics of Large Tumor Populations, a Potential Mechanism for Cancer Dormancy & Recurrence and Experimental Observation of Melanoma Progression in Zebrafish
Cancer, a family of over a hundred disease varieties, results in 600,000 deaths in the U.S. alone. Yet, improvements in imaging technology to detect disease earlier, pharmaceutical developments to shrink or eliminate tumors, and modeling of biological interactions to guide treatment have prevented …
-
Mathematical Models of Underlying Dynamics in Acute and Chronic Immunology
… our second and third models to explore breast cancer dormancy and T cell exhaustion. For our breast cancer dormancy model, we find that our model behaves similar to acute infections, but with constant antigen stimulation. Moreover, we observe the importance of immune protection on the long term …
-
Exploring the intrinsic and extrinsic factors that regulate breast cancer cell dormancy
Breast cancer can recur in patients months to decades after initial diagnosis and treatment. There is mounting evidence that dormant breast disseminated tumor cells (DTCs) exist in distant organs, whose reactivation results in cancer recurrence. However, the mechanisms that control tumor cell …
-
Investigating the molecular players involved in the control of transcriptional memory in metastasis
Metastasis is the principal cause of cancer-related mortality, yet the underlying molecular mechanisms supporting the invasion, dissemination, and dormancy of disseminated tumor cells (DTCs) remain unclear. In the metastasis cascade the DTCs encounter different microenvironmental stimuli and their …
-
Investigating cancer cell dormancy and recurrence in the bone marrow niche
Breast cancer is the most commonly diagnosed form of cancer in women. The spread of metastatic cancer cells to secondary sites, such as the bone marrow, is the leading cause of mortality. Upon entering the bone marrow, disseminated breast cancer cells enter a period of cycling quiescence, termed …
-
Snail1 Negatively Regulates Prostate Cancer Cell Growth, and Drives Prostate Cancer Cell Invasion and Migration in the Context of Tumor Microenvironment
Most prostate cancer (PCa) deaths are attributed to cancer metastasis. Despite the high efficacy of anti androgen-receptor signaling therapy in early disease, most PCa patients will develop resistance to the treatment. Roughly 36,000 PCa deaths will be recorded for the year 2025. This represents a …
-
Loss of Multiple Ferroptosis-Modulating Genes Accelerates Breast Cancer Recurrence via Promoting Exit from Cellular Dormancy
The majority of breast cancer mortality is due to recurrent metastatic disease, which is likely seeded by a dormant minimal residual disease (MRD) state. Better understanding of the cell state during dormancy and subsequent recurrence is thus necessary to improve patient outcomes. We first …
-
Transcriptomic Profiling and Molecular Characterisation of Dormant and Proliferating Breast Cancer Cells in the Brain
In metastatic breast cancer, brain metastases (BrM) incidence is 15-30% and effective therapies for BrM represent an unmet clinical need. Cancer dormancy describes the extended period of time in which disseminated tumour cells stop dividing and enter a clinically undetectable, reversible state of …
Page 1 of 2